Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

249 results about "Patent medicine" patented technology

A patent medicine, also known as a nostrum (from the Latin nostrum remedium, or "our remedy"), is a commercial product advertised (usually heavily) as a purported over-the-counter medicine, without regard to its effectiveness.

Chinese patent medicine for treating diabetes and technique for producing the same

The invention relates to a Chinese traditional patent medicine (the trade name being Rehmanniae Diabetes Capsule) for treating diabetes. The medicine comprises the following raw materials by weight portion: 30 to 60 portions of dwarf lilyturf tuber (also named dwarf lilyturf root), 30 to 60 portions of asparagus root (also named asparagus), 40 to 70 portions of figwort (also named radix scrophulariae), 70 to 150 portions of coptis root, 50 to 100 portions of oriental waterplantain rhizome, 20 to 50 portions of tuckahoe, 70 to 150 portions of cortex lycii radicis, 50 to 100 portions of tragacanth (also named radix astragali), 40 to 100 portions of cornus (also named cornus pulp), 30 to 60 portions of medlar, 50 to 100 portions of dry rehmanniae (also named fresh rehmanniae), 40 to 90 portions of prepared radix rehmanniae (also named prepared rhizome of rehmanniae), 20 to 60 portions of trichosanthin, 30 to 80 portions of panax, 20 to 40 portions of pilose antler and 50 to 100 portions of white muscardine silkworm. The Chinese traditional patent medicine plays a role in enhancing the sensibility of human body against insulin, reducing blood sugar and blood fat, regulating viscera and nourishing liver and kidney; moreover, the Chinese traditional patent medicine has scientific manufacturing process and can extract effective ingredients in raw materials.
Owner:连德峰

Traditional Chinese medicine for treating tumor

The present invention relates to a traditional Chinese medicine which is used for the treatment of cancers, in particular to a Chinese traditional patent medicine for treating lung cancer, cervical cancer, liver cancer, breast cancer, pancreatic cancer and malignant lymphoma. The present invention is characterized in that the present invention includes the raw materials with the following mix ratio by weight: 20 to 40 parts of honeycomb, 15 to 25 parts of oldworld arrowhead corm, 20 to 40 parts of hiraute shiny bugleweed herb, 30 to 50 parts of dahurian patrinia herb, 10 to 20 parts of gecko, 10 to 20 parts of pillbug, 30 to 50 parts of spreading hedyotis herb, 30 to 50 parts of common andrographis herb, 30 to 50 parts of barbed skullcap herb, 20 to 40 parts of common selfheal fruit-spike, 10 to 20 parts of Chinese thorowax root, 10 to 20 parts of figwort root and 10 to 20 parts of ginseng. The present invention has the effects of clearing heat, removing toxicity, promoting blood circulation, removing blood stasis, relieving swelling, resolving hard mass, benefiting qi and easing pain, which is applicable to the treatment of the patients with various mid-advanced tumors; the present invention can alleviate the clinical symptoms of the tumor patients, improve the cellular immune function of the patients, delay the development and the transfer of the cancers, improve the quality of life of the patients and prolong the survival period.
Owner:郑红梅

Honeysuckle quality evaluation method

The invention discloses a honeysuckle quality evaluation method. According to the honeysuckle quality evaluation method, chlorogenic acid, galuteolin and six iridoid glycoside ingredients in honeysuckle are determined, wherein the six iridoid glycoside ingredients are loganic acid, morroniside, loganin, chiratin, secoxyloganin and secologanin dimethyl acetal. The honeysuckle quality evaluation method disclosed by the invention has the advantages that the iridoid glycoside ingredients in the honeysuckle are included in a honeysuckle quality evaluation system for the first time, six representative iridoid glycoside ingredients in the honeysuckle are selected and determined at the same time for guaranteeing reliability and effectiveness of the quality evaluation method, and a dispersive solid phase extraction-high performance liquid chromatography (DSPE-HPLC) is established for the first time and used for detecting the six iridoid glycoside ingredients of different structures, so that reliability and effectiveness of honeysuckle quality evaluation are obviously improved, quality control level of traditional Chinese medicine honeysuckle and related patent medicines is further improved, and the honeysuckle quality evaluation method disclosed by the invention is significant on guidance of clinical application.
Owner:SHANDONG ANALYSIS & TEST CENT

Chinese traditional medicine ultra-fine comminution preforming device

The present invention relates to a Chinese traditional medicinal material hyperfine grinding and tablet forming device which is a field production device, which can wholly grind and sterilize by hyperpressure and mix uniformly to finally shape towards the articles of several grams till several decagrams. The present invention includes three parts of a hyperpressure grinding and sterilizing part, a shaking and mixing uniformly part, and a pressing part to be finished product. After the doctor prescribes a prescription, the present invention can achieve that the patient can bring the Chinese traditional tablet which is produced at the field and is similar to the western tablet back home to take. The difference between the western tablet and the Chinese traditional patent medicine is that the Chinese traditional tablet is produced towards the particular state of the patient illness completely according to flexible syndrome differentiations by the doctor, and the Chinese traditional tablet is not only convenient for taking, but the cost also is a fraction of the former tisane; the curative effect is not only good, but the charge is also only a part of the prior traditional method. The utility model conquers the problem of the prior art that a small dosage field processing towards an individual state of the illness can not be achieved. The device has simple structure, high degree of the automatization and small whole structure and is convenient for entering into the hospital and the drugstore.
Owner:邓小立

Biological proprietary Chinese medicine for preventing and treating diabetes

InactiveCN101293065ARegulates and lowers blood sugarRegulates and lowers triglyceridesAmphibian material medical ingredientsOrganic active ingredientsPollenBud
The invention discloses a biological Chinese traditional patent medicine for preventing and treating diabetes, and the biological Chinese traditional patent medicine is a preparation which is composed of the following components with the parts by weight: 3.5 to 4.5 parts of pilose Asiabell root powder, 2.5 to 3.5 parts of American ginseng powder, 3.5 to 4.5 parts of membranous milkvetch root powder, 1.5 to 2.5 parts of radix rehmanniae preparata powder, 2.5 to 3.5 parts of Indian buead powder, 2.5 to 3.5 parts of tuber fleeceflower root powder, 1.5 to 2.5 parts of giant knotweed rhizome powder, 2.5 to 3.5 parts of epimedium herb powder, 0.8 to 1.2 parts of ephedra herb powder, 3.5 to 4.5 parts of Mongolian snakegourd root powder, 1.5 to 2.5 parts of dwarf lilyturf tuber powder, 1.5 to 2.5 parts of hairyvein agrimonia herb and bud powder, 0.3 to 0.5 part of golden thread powder, 0.5 to 0.7 part of fried liquoric root powder, 1.5 to 2.5 parts of bitter gourd powder, 1.5 to 2.5 parts of leech powder, 1.5 to 2.5 parts of endothelium corneum gigeriae galli powder, 15 to 25 parts of Chinese forest frog powder, 15 to 25 parts of honey bee larva powder and 8 to 12 parts of chitosan, the raw materials are evenly mixed for preparing the preparation; the preparation can significantly reduce blood sugar and triglyceride levels of the patients with high blood lipids, so the biological Chinese traditional patent medicine preparation of the invention can improve and regulate the blood sugar and blood lipid levels of the patients with diabetes, and the side effects are fewer.
Owner:何明华

Pharmaceutical composition, preparing method and use the same

The invention discloses a medicine composition with anti-tumor and immune functions and a method of preparing the composition, a quality control method and the functions of the composition. The composition comprises artificial ox gallstone, honeysuckle flower, scolopendra, pangolin scale, toad venom, dandelion and other 18 traditional Chinese medicines; during preparation, the medicine composition fully displays the effective medicine by decocting, filtering, condensing, etc. different components; meanwhile, the invention also provides the quality control method of identifying the components and determining the content for the composition; the medicine composition of the invention has the effects of heat-toxin clearing, detumescence and removing blood stasis, strengthening body resistance, etc.; in addition, a plurality of tests prove that the medicine composition of the invention has anti-cancer and suppress cancer functions and is in particular applicable to the patients suffering from advanced gastrointestinal tract tumor; the medicine composition is free of toxicity, safety and reliable, can solve the side effect to the gastrointestinal tract brought by chemotherapy, can protect the hemogram and the immune function, has in particular obvious therapeutic effect to the patients suffering from stasis, and can become a novel anti-tumor Chinese traditional patent medicine.
Owner:王锋

Herbaceous plant solid beverage capable of relieving insomnia symptom and preparation method of beverage

The invention discloses a herbaceous plant solid beverage capable of relieving the insomnia symptom and a preparation method of the beverage. An active compound of the beverage comprises, by weight, 25-40 g of wheat, 3-5 g of licorice root, 9-15g g of jujube, 9-15 g of lilies, 9-15 g of semen ziziphi spinosae, 9-15 g of Chinese yam, 9-15 g of poria cocos, 9-15 g of longan and 9-15 g of roses. The patent medicine of the herbaceous plant solid beverage comprises, by weight, 3 g of wheat, 0.3 g of licorice root, 1 g of jujube, 1 g of lily, 1 g of semen ziziphi spinosae, 1 g of Chinese yam, 1 g of poria cocos, 1 g of longan and 1 g of roses. According to the beverage, pure traditional Chinese medicine herbaceous raw materials are used and conform to the monarch, minister, assistant and guide principle, wheat and semen ziziphi spinosae are used as monarch drugs, licorice root and poria cocos are used as minister drugs, jujube is used as the assistant drug, licorice root is used as the guide drug, and the lilies, the Chinese yam, the longan and the roses are added and act together, so that the herbaceous plant solid beverage has the effects of moistening and nourishing, heat clearing and restlessness relieving, the herbaceous plant solid beverage aims at relieving mental stress, resisting anxiety and relieving depression, and the beverage is free of dependence and toxic and side effects.
Owner:广州绍康公生物科技有限责任公司

Repeated medication identification method and device, terminal and readable storage medium

PendingCN109616174AConducive to the regulation of overprescribing drugsFinanceDrug and medicationsDiseaseRegimen
The invention provides a repeated medication identification method and device, a terminal and a readable storage medium. The recognition method comprises the steps that diagnosis and treatment detailsof an insured person are acquired, and Chinese patent medicine recorded in the diagnosis and treatment details is recognized; determining disease types of the insured persons according to the diagnosis and treatment details, and obtaining medication ranges corresponding to the disease types; Judging whether the recorded Chinese patent medicine belongs to a medication range or not; if the recordedChinese patent medicine belongs to the medication range, marking the Chinese patent medicine, and judging whether the type of the marked Chinese patent medicine is greater than a preset threshold value or not; and if the type of the marked Chinese patent medicine is greater than a preset threshold value, marking that the insured person has a repeated medication behavior. On the basis of the artificial intelligence technology, the related data of the insured person can be obtained from the medicine management system, the behavior that a doctor overflows medicine can be supervised, especially nonstandard behaviors such as random combined medication, random dosage increase and random treatment course prolongation can be supervised, and the problems that the burden of a patient is increased and medical resources are wasted due to repeated medication are avoided.
Owner:PING AN MEDICAL & HEALTHCARE MANAGEMENT CO LTD

Method for simultaneously measuring six iridoid glycoside ingredients in honeysuckle flowers

The invention discloses a method for simultaneously measuring six iridoid glycoside ingredients in honeysuckle flowers. The six iridoid glycoside ingredients, namely, loganic acid, morroniside, loganin, chiratin, secoxyloganin and secologanin dimethyl acetal, of different structures in honeysuckle flowers are measured simultaneously based on a DSPE-HPLC method for the first time; by means of the method, the linearly dependent coefficients are larger than 0.999, the detection limit is 0.026-0.057 micrograms / mL, the recovery rates of all target ingredients range from 90.5% to 102.1%, the relative standard deviation (RSD) ranges from 0.85% to 1.74%, and the method has the advantages that the using amount of an organic solvent is small, the purification and concentration effects are good, the recovery rates of targets are high, the sensitivity is high, and operation is easy. The fast and efficient extraction, purification and analysis method suitable for iridoid glycoside ingredients in medical materials such as honeysuckle flowers is developed, and has great significance on further developing the acting mechanism of iridoid glycoside ingredients, establishing quality standards, increasing medical material and related patent medicine quality control levels and guiding clinical application.
Owner:SHANDONG ANALYSIS & TEST CENT

Compound composition for treating chloasma and stimulating evacuation of the bowels and uses thereof

The present invention relates to a compound composition for the treatment of chloasma and constipation and the application, which pertains to the technical field of the health care products of Chinese traditional patent medicine and the traditional Chinese medicine. The present invention contains the raw materials components with the following mix ratio by weight: 3 to 50 percent traditional Chinese medicine extract, 10 to 55 percent xylooligosaccharide, 4 to 20 percent grape seed extract, 2 to 20 percent soybean extract, 4 to 20 percent vitamin C and 4 to 20 percent of vitamin E. The present invention uses the conventional production process to carry out the extraction of the active ingredients, the conventional excipients are also added according to the mix ratio and the different formulations, and then the final product which can be tablets, granules or capsules is made by full mixing. The present invention is characterized by the synergistic effect of a plurality of components; the present invention uses the health care methods of regulating qi, activating blood circulation, regulating the functions of qi and blood, lubricating bowel and promoting defecation for the people group with hepatic qi stagnation and stagnation of blood stasis, which has significant efficacy and no toxicity or side effects for the prevention and treatment of chloasma and constipation diseases.
Owner:HANGZHOU XINFU TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products